23.04.2014 • News

Christophe Vidonne and Dr. Ralph Billo about Novartis' Buffer Management Concept

"From an end-to-end perspective, what really counts is what remains visible and measurable for our customers. It is not only about key performance indicators and delivery service but also the ability to properly communicate accurate and meaningful supply chain information in a multi-cultural and cross-functional environment across geographies."

Christophe Vidonne, Head Supply Chain Management and Dr. Ralph Billo, Head Global Supply Chain Management, Novartis

Novartis Animal Health (NAH) is a leading global provider of solutions for the prevention and treatment of various widespread animal diseases and parasite infestations. To maintain and even strengthen their market position, NAH are eager to continuously improve their supply chain performance as one of the key drivers of the company's success. Therefore, a few years ago NAH triggered a state-of-the-art supply chain planning initiative with a special focus on redesigning their replenishment framework. The main change concerned a transformation from push to pull replenishment for selected products within their portfolio. The successful realization of the benefits of pull replenishment was enabled by the implementation of buffer management as a Lean replenishment mode. This enabled NAH not only to reduce supply chain inventories but also to increase planning accuracy while reducing required planning efforts. These positive impacts underline the benefits of the supply chain initiative and prove that NAH has come a long way towards a truly integrated supply chain.

Learn more about Lean Supply Chain Planning, just visit www.leansupplychainplanning.com.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.